Cefditoren is a broad-spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7 of the cephem skeleton. It is generally administered as its orally absorbed pivaloyloxymethyl ester prodrug and is used to treat mild to moderate infections caused by susceptible microorganisms, including acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections. It functions as an antibacterial drug, and it is a cephalosporin and a carboxylic acid.
